Khalil Ali Ahmad Selected Research

Khalil Ali Ahmad Research Topics

Disease

9	Pain (Aches) 03/2023 - 06/2019
6	Neuralgia (Stump Neuralgia) 03/2023 - 01/2021
6	Hyperalgesia 03/2023 - 02/2020
4	Chronic Pain 03/2023 - 02/2020
4	Hypersensitivity (Allergy) 03/2023 - 01/2021
3	Bone Neoplasms (Bone Cancer) 01/2021 - 02/2020
2	Peripheral Nerve Injuries 10/2021 - 01/2021
2	Prostatitis 06/2019 - 10/2018
2	Cardiotoxicity 05/2019 - 06/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 06/2018
2	Hypertension (High Blood Pressure) 06/2018 - 04/2017
1	Multiple Myeloma 10/2021
1	Erythema Nodosum 10/2021
1	Body Weight (Weight, Body) 01/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Cancer Pain 02/2020
1	Inflammation (Inflammations) 06/2019
1	Pelvic Pain 10/2018
1	Male Infertility (Male Sterility) 10/2018
1	Atherosclerosis 06/2018

Drug/Important Bio-Agent (IBA)

5	Dynorphins (Dynorphin)IBA 03/2023 - 02/2020
5	Minocycline (Cyclops)FDA LinkGeneric 03/2023 - 01/2021
4	EndorphinsIBA 10/2021 - 02/2020
4	AntioxidantsIBA 10/2018 - 04/2017
3	Narcotic Antagonists (Opioid Antagonists)IBA 03/2023 - 01/2021
3	Formaldehyde (Formol)FDA Link 03/2023 - 01/2021
3	Interleukin-10 (Interleukin 10)IBA 10/2021 - 02/2020
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2018
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2023 - 01/2021
2	protopanaxadiolIBA 03/2023 - 01/2021
2	Exenatide (Byetta)FDA Link 10/2021 - 01/2021
2	Glucagon-Like Peptide-1 ReceptorIBA 10/2021 - 01/2021
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2021 - 09/2020
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2021 - 01/2021
1	ginsenoside M1IBA 03/2023
1	Nonprescription Drugs (Patent Medicines)IBA 03/2023
1	sanqiIBA 03/2023
1	GinsenosidesIBA 03/2023
1	Estrogen Receptor AntagonistsIBA 03/2023
1	ginsenoside Rb1IBA 03/2023
1	PowdersIBA 03/2023
1	pomalidomideIBA 10/2021
1	InterleukinsIBA 10/2021
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 10/2021
1	Thalidomide (Thalomid)FDA Link 10/2021
1	Lenalidomide (CC 5013)FDA Link 10/2021
1	CytokinesIBA 10/2021
1	Opioid Receptors (Opioid Receptor)IBA 10/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	bulleyaconitine AIBA 01/2021
1	Pregabalin (Lyrica)FDA Link 01/2021
1	Eplerenone (Inspra)FDA LinkGeneric 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	AlkaloidsIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	LigandsIBA 01/2021
1	Mesylates (Mesylate)IBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	Naloxone (Narcan)FDA LinkGeneric 01/2021
1	mirogabalinIBA 01/2021
1	Calcium Channels (Calcium Channel)IBA 01/2021
1	Mifepristone (RU 486)FDA Link 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Opioid Peptides (Opioid Peptide)IBA 09/2020
1	cinobufaginIBA 02/2020
1	chan su (ChanSu)IBA 02/2020
1	bufadienolideIBA 02/2020
1	Cholinergic ReceptorsIBA 02/2020
1	methyllycaconitineIBA 02/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 02/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2019
1	AutoantigensIBA 06/2019
1	Peptides (Polypeptides)IBA 06/2019
1	Hematoxylin (Haematoxylon)IBA 06/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	LipidsIBA 10/2018
1	SilymarinIBA 06/2018
1	Antihypertensive Agents (Antihypertensives)IBA 04/2017
1	PolyphenolsIBA 04/2017
1	alpha-Tocopherol FDA Link 04/2017
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 04/2017

Therapy/Procedure

4	Spinal Injections 10/2021 - 01/2021
4	Ligation 10/2021 - 01/2021
3	Therapeutics 01/2021 - 04/2017
1	Injections 01/2021
1	Electroacupuncture 09/2020
1	Analgesia 09/2020